(Q37854063)

24 August 2017

1 reference

title

Liposomal vaccine delivery systems (English)

1 reference

24 August 2017

1 reference

Malou Henriksen-Lacey

series ordinal

1

1 reference

24 August 2017

5

1 reference

24 August 2017

Peter Andersen

3

0 references

Karen Smith Korsholm

series ordinal

2

object named as

Karen Smith Korsholm

1 reference

24 August 2017

4

Yvonne Perrie

1 reference

24 August 2017

language of work or name

English

0 references

publication date

18 March 2011

1 reference

Expert Opinion on Drug Delivery

24 August 2017

published in

1 reference

24 August 2017

volume

8

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

505-519

1 reference

Vaccine adjuvants: current challenges and future approaches.

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Towards an understanding of the adjuvant action of aluminium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

(How) do aluminium adjuvants work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

The controversial relationship between NLRP3, alum, danger signals and the next-generation adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Recent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Cationic liposomes as vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Physical principles of membrane organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Engineering liposomes for drug delivery: progress and problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Drug entrapment in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Vaccine entrapment in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Liposomes as immunoadjuvants and vaccine carriers: antigen entrapment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Regulated portals of entry into the cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Vesicle size influences the trafficking, processing, and presentation of antigens in lipid vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Nanoparticles target distinct dendritic cell populations according to their size

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Liposome-mediated DNA vaccination: the effect of vesicle composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

In vivo activity of cationic immune stimulating complexes (PLUSCOMs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Cage-like complexes formed by DOTAP, Quil-A and cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Influence of phospholipid composition on the adjuvanticity and protective efficacy of liposome-encapsulated Leishmania donovani antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Surface-linked liposomal antigen induces ige-selective unresponsiveness regardless of the lipid components of liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Immunogenicity of liposomal model membranes in mice: dependence on phospholipid composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Comparative calorimetric and spectroscopic studies of the effects of cholesterol and epicholesterol on the thermotropic phase behaviour of dipalmitoylphosphatidylcholine bilayer membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Cholesterol inclusion in liposomes affects induction of antigen-specific IgG and IgE antibody production in mice by a surface-linked liposomal antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

The path to a successful vaccine adjuvant--'the long and winding road'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Immunological concepts of vaccine adjuvant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Molecular and cellular signatures of human vaccine adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Targeting dendritic cells with antigen-containing liposomes: antitumour immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Antigen-containing liposomes engrafted with flagellin-related peptides are effective vaccines that can induce potent antitumor immunity and immunotherapeutic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Design of a liposomal candidate vaccine against Pseudomonas aeruginosa and its evaluation in triggering systemic and lung mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Cytotoxic targeting of F9 teratocarcinoma tumours with anti-ED-B fibronectin scFv antibody modified liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Eleven years of Inflexal V-a virosomal adjuvanted influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Effect of phosphorylation of ovalbumin on adsorption by aluminum-containing adjuvants and elution upon exposure to interstitial fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Liposome-mediated DNA immunisation via the subcutaneous route

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

A liposomal peptide vaccine inducing CD8+ T cells in HLA-A2.1 transgenic mice, which recognise human cells encoding hepatitis C virus (HCV) proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Robust immune responses elicited by a fully synthetic three-component vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Induction of effective and antigen-specific antitumour immunity by a liposomal ErbB2/HER2 peptide-based vaccination construct

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

L-BLP25: a peptide vaccine strategy in non small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Mucosal immunization against hepatitis A: antibody responses are enhanced by co-administration of synthetic oligodeoxynucleotides and a novel cationic lipid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Vaccination with the recombinant allergen ProDer p 1 complexed with the cationic lipid DiC14-amidine prevents allergic responses to house dust mite

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

The effects of salt on the physicochemical properties and immunogenicity of protein based vaccine formulated in cationic liposome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Mincle is a long sought receptor for mycobacterial cord factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

New generation of liposomes called archaeosomes based on natural or synthetic archaeal lipids as innovative formulations for drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

The virosomal adjuvanted influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Archaeosome adjuvants: immunological capabilities and mechanism(s) of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Archaeosome immunostimulatory vaccine delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Host innate immune receptors and beyond: making sense of microbial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

ESAT-6 subunit vaccination against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

T-helper 1 and T-helper 2 adjuvants induce distinct differences in the magnitude, quality and kinetics of the early inflammatory response at the site of injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

DiC14-amidine cationic liposomes stimulate myeloid dendritic cells through Toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Cationic lipids activate cellular cascades. Which receptors are involved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Incorporation of a synthetic mycobacterial monomycoloyl glycerol analogue stabilizes dimethyldioctadecylammonium liposomes and potentiates their adjuvant effect in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

A simple mycobacterial monomycolated glycerol lipid has potent immunostimulatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Comparison of immune response in sheep immunized with DNA vaccine encoding Toxoplasma gondii GRA7 antigen in different adjuvant formulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

The novel adjuvant IC31 strongly improves influenza vaccine-specific cellular and humoral immune responses in young adult and aged mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Mode of action of adjuvants: implications for vaccine safety and design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

T-cell quality in memory and protection: implications for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Lethal and adjuvant activities of cord factor (trehalose-6,6'-dimycolate) and synthetic analogs in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

CAF01 liposomes as a mucosal vaccine adjuvant: In vitro and in vivo investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Vaxfectin: a versatile adjuvant for plasmid DNA- and protein-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Novel generation mycobacterial adjuvant based on liposome-encapsulated monomycoloyl glycerol from Mycobacterium bovis bacillus Calmette-Guérin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Adjuvant properties of a simplified C32 monomycolyl glycerol analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

The adjuvant CLDC increases protection of a herpes simplex type 2 glycoprotein D vaccine in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Treatment with cationic liposome-DNA complexes (CLDCs) protects mice from lethal Western equine encephalitis virus (WEEV) challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Mucosal immunotherapy for protection from pneumonic infection with Francisella tularensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Transcutaneous immunization by lipoplex-patch based DNA vaccines is effective vaccination against Japanese encephalitis virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

A liposome-based platform, VacciMax, and its modified water-free platform DepoVax enhance efficacy of in vivo nucleic acid delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

A comparative study of cationic liposome and niosome-based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines; immunity, pathology and protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

Trehalose preserves DDA/TDB liposomes and their adjuvant effect during freeze-drying

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2011.558081

10.1517/17425247.2011.558081

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference